ARMP AMEX
Armata Pharmaceuticals, Inc.
1W: -5.9%
1M: -36.4%
3M: -35.3%
YTD: -46.3%
1Y: +18.9%
3Y: +25.3%
5Y: -3.3%
$3.52
+0.21 (+6.34%)
Weekly Expected Move ±15.3%
$2
$3
$4
$4
$5
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
Supply Chain Overview
6 relationships6
As Filer
counterparties named
0
As Counterparty
mentioned by others
2
Rel. Types
2021-10-29
Earliest Filing
2022-02-11
Latest Filing
investor: 5
partner: 1
Counterparties (Filed by ARMP)
6 relationshipsCompanies named in ARMP's SEC 8-K filings as business counterparties.
| Counterparty | Ticker | Relationship | Summary | Filing Date | SEC |
|---|---|---|---|---|---|
| Innoviva Strategic Opportunities LLC | INVA | investor | Purchased shares and warrants in a private placement | 2022-02-11 | View |
| Innoviva, Inc. | INVA | investor | Parent company of Innoviva Strategic Opportunities LLC | 2022-02-11 | View |
| 5005 McConnell Avenue, LLC | — | partner | Landlord in a lease agreement for office space | 2021-11-02 | View |
| Innoviva Strategic Opportunities LLC | INVA | investor | Purchased 1,212,122 shares in a private placement | 2021-10-29 | View |
| Cystic Fibrosis Foundation | — | investor | Purchased 909,091 shares in a private placement | 2021-10-29 | View |
| Innoviva, Inc. | INVA | investor | Signatory to voting agreement with Innoviva Strategic Opportunities LLC | 2021-10-29 | View |
Recent 8-K Filings (20)
| Filing Date | Description | Type | SEC |
|---|---|---|---|
| 2026-09-23 | Other Events; Exhibits | View | |
| 2026-09-14 | Regulation FD; Exhibits | View | |
| 2026-08-12 | Earnings Release; Exhibits | View | |
| 2026-07-20 | Regulation FD; Exhibits | View | |
| 2026-07-20 | Officer/Director Change; Exhibits | View | |
| 2026-07-13 | Regulation FD; Exhibits | View | |
| 2026-06-24 | Officer/Director Change | View | |
| 2026-06-23 | Other Events; Exhibits | View | |
| 2026-06-16 | Shareholder Vote | View | |
| 2026-05-13 | Material Agreement; Earnings Release; Financial Obligation; Regulation FD; Exhibits | Agreement | View |
| 2026-05-07 | Regulation FD; Exhibits | View | |
| 2026-04-27 | Officer/Director Change; Regulation FD; Exhibits | View | |
| 2026-04-02 | Other Events | View | |
| 2026-03-25 | Earnings Release; Exhibits | View | |
| 2026-02-23 | Regulation FD Disclosure; Financial Statements and Exhibits | View | |
| 2026-01-26 | Entry into Material Definitive Agreement; Financial Statements and Exhibits | Agreement | View |
| 2026-01-13 | Regulation FD Disclosure; Financial Statements and Exhibits | View | |
| 2025-12-01 | Entry into Material Definitive Agreement; Financial Statements and Exhibits | Agreement | View |
| 2025-11-12 | Results of Operations and Financial Condition; Financial Statements and Exhibits | View | |
| 2025-10-22 | Regulation FD Disclosure; Financial Statements and Exhibits | View |
Data extracted from SEC EDGAR 8-K filings using NLP. Relationships are as disclosed in filing text.
Covers 2021–2026. View on SEC EDGAR